Madrigal Pharmaceuticals grants equity awards to 23 new employees
MDGL•Madrigal Pharmaceuticals granted equity awards to 23 new non-executive employees on Nov. 1 and Nov. 14, 2026, including options to purchase 842 shares and 8,296 restricted stock units.
1. Equity awards
The awards were granted under the company’s 2025 Inducement Plan. All options were granted on Nov. 1 at an exercise price of $430.36 per share; options and restricted stock units vest over time and require continued employment on each vesting date.




